RESUMO
BACKGROUND: The finding of new biomarkers is needed to have a better sub-classification of primary renal tumors (RCC) as well as more reliable predictors of outcome and therapy response. In this study, we evaluated the role of circulating FGF21, an endocrine factor, as a diagnostic and prognostic biomarker for ccRCC. MATERIALS AND METHODS: Serum samples from healthy controls (HC), clear cell and chromophobe RCC cancer patients were obtained from the serum biobank "Biobanco Público de Muestras Séricas Oncológicas" (BPMSO) of the "Instituto de Oncología "Ángel H. Roffo". Serum FGF21 and leptin were measured by ELISA while other metabolic markers were measured following routinely clinical procedures. RESULTS: One of our major findings was that FGF21 levels were significantly increased in ccRCC patients compared with HC. Moreover, we showed an association between the increased serum FGF21 levels and the shorter disease free survival in a cohort of 98 ccRCC patients, after adjustment for other predictors of outcome. CONCLUSION: Our results suggest that higher FGF21 serum level is an independent prognostic biomarker, associated with worse free-disease survival.
RESUMO
Colorectal cancer (CRC) is the third most common malignant neoplasm worldwide. The objective of this study was to examine whether carnosic acid (CA), the main antioxidant compound of Rosmarinus officinalis L., would inhibit the cell viability of three CRC cell lines: Caco-2, HT29 and LoVo in a dose-dependent manner, with IC50 values in the range of 24-96 µM. CA induced cell death by apoptosis in Caco-2 line after 24 h of treatment and inhibited cell adhesion and migration, possibly by reducing the activity of secreted proteases such as urokinase plasminogen activator (uPA) and metalloproteinases (MMPs). These effects may be associated through a mechanism involving the inhibition of the COX-2 pathway, because we have determined that CA downregulates the expression of COX-2 in Caco-2 cells at both the mRNA and protein levels. Therefore, CA modulates different targets involved in the development of CRC. These findings indicate that carnosic acid may have anticancer activity and may be useful as a novel chemotherapeutic agent.
Assuntos
Abietanos/farmacologia , Antineoplásicos Fitogênicos/farmacologia , Movimento Celular/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Neoplasias Colorretais/patologia , Extratos Vegetais/farmacologia , Inibidores de Proteases/farmacologia , Apoptose/efeitos dos fármacos , Células CACO-2 , Adesão Celular/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Neoplasias Colorretais/genética , Neoplasias Colorretais/metabolismo , Ciclo-Oxigenase 2/genética , Ciclo-Oxigenase 2/metabolismo , Relação Dose-Resposta a Droga , Regulação para Baixo , Células HT29 , Humanos , Concentração Inibidora 50 , Metaloproteinase 2 da Matriz/metabolismo , Metaloproteinase 9 da Matriz/metabolismo , Inibidores de Metaloproteinases de Matriz , RNA Mensageiro/metabolismo , Fatores de Tempo , Ativador de Plasminogênio Tipo Uroquinase/antagonistas & inibidores , Ativador de Plasminogênio Tipo Uroquinase/metabolismoRESUMO
This review presents recent information about the cross-talk between the tumor cells and the microenvironment in the target organ of metastasis at the premetastatic and metastatic stage. The development of metastatic foci is driven not only by the tumor cells intrinsic properties, but also by the interplay with resident and foreign cells located at particular niches in the target organ. The primary tumor modulates the metastatic target through the production of soluble factors that mobilize cells from distant organs like the bone marrow, which in turn localize in the metastatic niche. There is also strong evidence indicating that some primary tumors induce a fertile ground for the tumor cell at the target organ even before the arrival of the disseminated tumor cell (premetastatic niche). The relationship between the players of the metastatic setting is dynamic and shows a high degree of plasticity. Tumor cells change through the acquisition of genetic and/or epigenetic alterations that provide adaptive advantages and the metastatic niche is remodeled by incoming cell types or newly secreted soluble mediators, as a result a reciprocal dialogue is established that invokes new levels of molecular and cellular complexity. Unraveling the mechanisms that sustain the metastatic niche will allow a better understanding of the biology of the disseminated tumor cell, the design of new therapeutic approaches and, hopefully, the improvement of cancer patients' survival.
Assuntos
Células da Medula Óssea , Comunicação Celular , Metástase Neoplásica/patologia , Células Neoplásicas Circulantes , Lesões Pré-Cancerosas/patologia , Microambiente Tumoral , Animais , Células da Medula Óssea/metabolismo , Células da Medula Óssea/patologia , Progressão da Doença , Humanos , Células Neoplásicas Circulantes/metabolismo , Células Neoplásicas Circulantes/patologia , Especificidade de Órgãos , Lesões Pré-Cancerosas/metabolismoRESUMO
BACKGROUND: Although hyperfibrinogenemia and insulin resistance are common in obesity and diabetes mellitus, the impact of obesity per se on fibrinogen turnover and the insulin effects on fibrinogen and protein kinetics is unknown. METHODS: We measured fibrinogen and albumin fractional (FSR) and absolute (ASR) synthesis rates, as well as protein turnover, in non-diabetic, obese and in control male subjects both before and following an euglycemic, euaminoacidemic, hyperinsulinemic clamp, using L-[(2)H(3)]-Leucine isotope infusion. RESULTS: In the obese, basal fibrinogen concentrations was approximately 25% greater (p < 0.035), and fibrinogen pool approximately 45% greater (p < 0.005), than in controls. Both FSR and ASR of fibrinogen were similar to control values. With hyperinsulinemia, although fibrinogen FSR and ASR were not significantly modified with respect to baseline in either group, fibrinogen ASR resulted to be approximately 50% greater in the obese than in controls (p < 0.015). Hyperinsulinemia equally stimulated albumin synthesis and suppressed leucine appearance from endogenous proteolysis in both groups. Amino acid clearance was also similar. In the obese, the insulin-mediated glucose disposal was approximately 50% lower (p < 0.03) than in controls, and it was inversely correlated with fibrinogen ASR during the clamp in both groups (r = - 0.58). CONCLUSIONS: In obese, non-diabetic males, post absorptive fibrinogen production is normal. Whole-body amino acid disposal, basal and insulin-responsive protein degradation, and albumin synthesis are also normal. However, the greater fibrinogen ASR in the obese with hyperinsulinemia, and the inverse relationship between insulin sensitivity and clamp fibrinogen production, suggest a role for hyperinsulinemia and/or insulin resistance on fibrinogen production in obesity.
Assuntos
Fibrinogênio/metabolismo , Insulina/farmacologia , Obesidade/metabolismo , Adulto , Aminoácidos/metabolismo , Glicemia/metabolismo , Pressão Sanguínea , Índice de Massa Corporal , Superfície Corporal , Proteína C-Reativa/metabolismo , Colesterol/sangue , Fibrinogênio/efeitos dos fármacos , Humanos , Insulina/sangue , Molécula 1 de Adesão Intercelular/sangue , Interleucina-6/sangue , Masculino , Pessoa de Meia-Idade , Obesidade/sangue , Obesidade/fisiopatologia , Valores de Referência , Trombomodulina/sangue , Fator de Necrose Tumoral alfa/sangue , Molécula 1 de Adesão de Célula Vascular/sangueRESUMO
Glypican-3 (GPC3) is a proteoglycan involved in proliferation and cell survival. Several reports demonstrated that GPC3 is downregulated in some tumors, such as breast cancer. Previously, we determined that GPC3 reexpression in the murine mammary adenocarcinoma LM3 cells induced an impairment of their invasive and metastatic capacities, associated with a decrease of their motility and an increase of their cell death. We demonstrated that GPC3 inhibits canonical Wnt signaling, as well as it activates non canonical pathway. Now, we identified signaling pathways responsible for the pro-apoptotic role of GPC3 in LM3 cells. We found for the first time that GPC3 inhibits the PI3K/Akt anti-apoptotic pathway while it stimulates the p38MAPK stress-activated one. We report a concomitant modulation of CDK inhibitors as well as of pro- and anti-apoptotic molecules. Our results provide new clues regarding the mechanism involved in the modulation induced by GPC3 of mammary tumor cell growth and survival.
Assuntos
Adenocarcinoma/metabolismo , Apoptose/fisiologia , Neoplasias da Mama/metabolismo , Glipicanas/metabolismo , Transdução de Sinais/fisiologia , Adenocarcinoma/genética , Animais , Western Blotting , Neoplasias da Mama/genética , Linhagem Celular Tumoral , Separação Celular , Feminino , Citometria de Fluxo , Expressão Gênica , Regulação Neoplásica da Expressão Gênica , Glipicanas/genética , Imuno-Histoquímica , Camundongos , Fosfatidilinositol 3-Quinases/metabolismo , Proteínas Proto-Oncogênicas c-akt/metabolismo , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Proteínas Quinases p38 Ativadas por Mitógeno/metabolismoRESUMO
BACKGROUND AND AIM: Hyperfibrinogenemia, a cardiovascular risk factor, is frequent in hypertension and largely unexplained. In this study, we measured fibrinogen production and whole-body protein turnover under both basal and hyperinsulinemic states, in hypertensive [H] and control [C] subjects, using a leucine stable isotope tracer and precursor-product relationships. METHODS AND RESULTS: Since hypertension is often a feature of the "metabolic", insulin resistance syndrome, which in turn affects both fibrinogen kinetics and whole-body protein turnover, we selected hypertensive subjects without the metabolic syndrome. Following basal measurements, an euglycemic, approximately euaminoacidemic, hyperinsulinemic clamp was performed, with plasma insulin raised to 700-900 pmol/L. In H, rates of the fractional and absolute synthesis (FSR and ASR, respectively) of fibrinogen were 30%-40% greater (p<0.05 or less) than in C in both states, whereas leucine turnover was normal. Hyperinsulinemia did not modify fibrinogen synthesis in either group with respect to baseline, whereas it suppressed leucine appearance from endogenous proteolysis by approximately 40% to same extent in both groups. Amino acid clearance was similar in both the H and C subjects. In H, the insulin-mediated glucose disposal (M) was approximately 25% lower, (although insignificantly) than in controls, showing no overall insulin resistance. There was an inverse correlation between M and fibrinogen FSR during the clamp. CONCLUSIONS: In essential hypertension fibrinogen production is increased, is not further stimulated by insulin, and is inversely related to insulin sensitivity at high-physiological insulin concentrations. Amino acid disposal and basal as well as insulin-responsive protein degradation rates are instead normal.
Assuntos
Fibrinogênio/metabolismo , Hiperinsulinismo/metabolismo , Hipertensão/metabolismo , Insulina/administração & dosagem , Adulto , Biomarcadores/metabolismo , Glicemia/metabolismo , Estudos de Casos e Controles , Deutério , Fibrinogênio/biossíntese , Glucose/administração & dosagem , Técnica Clamp de Glucose , Humanos , Hiperinsulinismo/sangue , Hipertensão/sangue , Técnicas de Diluição do Indicador , Infusões Intravenosas , Insulina/sangue , Cinética , Leucina/administração & dosagem , Masculino , Pessoa de Meia-Idade , Peptídeo Hidrolases/metabolismo , Regulação para CimaRESUMO
In plasma and serum, the presence of high-abundance proteins can overwhelm the signals of low-abundance proteins, which then become undetectable either by two-dimensional gels or chromatographic techniques. Therefore, depletion of abundant proteins is a prerequisite to detect low-abundance components. Furthermore, the regeneration of pre-purification tools could be money-saving. We applied an affinity chromatography kit to remove albumin and the immunoglobulin chains from plasma and propose a simple and effective technical procedure for the regeneration of these affinity columns.
Assuntos
Imunoglobulina G/sangue , Proteômica/métodos , Albumina Sérica/análise , Albumina Sérica/metabolismo , Cromatografia de Afinidade , Eletroforese em Gel Bidimensional , Humanos , Fatores de TempoRESUMO
Glypican-3 (GPC3), a proteoglycan bound to the cell membrane through a GPI anchor, is widely expressed in the embryo but down regulated in most adult tissues, with some exceptions as mammary cells. GPC3 is involved in the regulation of cell proliferation and survival in specific cell types. LM3, a murine mammary tumor cell line unable to express GPC3, was stably transfected with the rat GPC3 gene to analyze its role in tumor progression. Upon injection into syngeneic BALB/c mice LM3-GPC3 clones showed less local invasiveness and developed fewer spontaneous and experimental lung metastasis than controls. GPC3-expressing cells were more sensitive to apoptosis induced by serum depletion, exhibited a delay in the first steps of spreading and were less motile than controls. On the other hand, LM3-GPC3 cells were significantly more adherent to FN than control ones. We observed that GPC3 transfectants presented a higher expression of E-cadherin and beta-catenin, molecules whose down regulation has been associated with tumor progression. Exogenous TGF-beta increased MMP-9 activity in both control and GPC3-expressing cells, but did not modulate MMP-2. Contrarily, GPC3 expression prevented the increase of MMP-2 activity induced by IGF-II. Our results suggest that GPC3 has a protective role against mammary cancer progression.
Assuntos
Proteoglicanas de Heparan Sulfato/genética , Neoplasias Pulmonares/metabolismo , Neoplasias Mamárias Animais/metabolismo , Animais , Northern Blotting , Western Blotting , Caderinas/metabolismo , Linhagem Celular Tumoral , Proteínas do Citoesqueleto/metabolismo , Modelos Animais de Doenças , Feminino , Glipicanas , Proteoglicanas de Heparan Sulfato/metabolismo , Imuno-Histoquímica , Fator de Crescimento Insulin-Like II/farmacologia , Neoplasias Pulmonares/secundário , Neoplasias Mamárias Animais/patologia , Camundongos , Camundongos Endogâmicos BALB C , Invasividade Neoplásica , Metástase Neoplásica , Ratos , Transativadores/metabolismo , Transfecção , Fator de Crescimento Transformador beta/farmacologia , beta CateninaRESUMO
During tumor development, growth factors may act in autocrine manner stimulating cell proliferation, or in paracrine manner affecting the microenvironment of the tumor and modulating the immune system. Murine mammary adenocarcinoma M3 tumor bearers develop lung metastases and leukocytosis during its evolution. Previously we described that M3 conditioned media enhanced metastasis incidence, when it was inoculated in tumor-operated mice. In the present study we determine that spleen cells from M3 tumor operated mice treated with M3 conditioned media, were able to transfer the capacity to enhance metastasis to other tumor operated mice. Spleen cells have immune suppressor activity that could be reversed by cyclophosfamide treatment. M3 tumor cells secrete GM-CSF, which is able to promote in vitro proliferation of M3 cells as well as spleen cells. This proliferation could be abrogated by the addition of anti-GM-CSF. We report that the GM-CSF secreted by M3 tumor cells had stimulatory activity on M3 tumor cell and lymphocyte proliferation.
Assuntos
Adenocarcinoma/imunologia , Adenocarcinoma/metabolismo , Fator Estimulador de Colônias de Granulócitos e Macrófagos/metabolismo , Neoplasias Mamárias Animais/imunologia , Neoplasias Mamárias Animais/metabolismo , Adenocarcinoma/patologia , Animais , Antineoplásicos Alquilantes/farmacologia , Células da Medula Óssea/metabolismo , Divisão Celular , Células Cultivadas , Ensaio de Unidades Formadoras de Colônias , Meios de Cultivo Condicionados/farmacologia , Ciclofosfamida/farmacologia , Progressão da Doença , Feminino , Neoplasias Pulmonares/secundário , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Metástase Neoplásica , Baço/citologia , Baço/metabolismoRESUMO
Fruit's decoctions of Passiflora edulis and P. foetida var. albiflora were evaluated for the inhibition of activity of gelatinase MMP-2 and MMP-9, two metallo-proteases involved in the tumour invasion, metastasis and angiogenesis. Both water extracts, at different concentrations, inhibited the enzymes.
Assuntos
Antineoplásicos Fitogênicos/farmacologia , Inibidores de Metaloproteinases de Matriz , Passiflora , Fitoterapia , Extratos Vegetais/farmacologia , Inibidores Teciduais de Metaloproteinases/farmacologia , Antineoplásicos Fitogênicos/administração & dosagem , Antineoplásicos Fitogênicos/uso terapêutico , Relação Dose-Resposta a Droga , Frutas , Humanos , Extratos Vegetais/administração & dosagem , Extratos Vegetais/uso terapêutico , Inibidores Teciduais de Metaloproteinases/administração & dosagem , Inibidores Teciduais de Metaloproteinases/uso terapêuticoAssuntos
Humanos , Masculino , Adulto , Feminino , Pessoa de Meia-Idade , Astrocitoma , Neoplasias do Sistema Nervoso Central , Expressão Gênica , Glioblastoma , Glioma , Biomarcadores Tumorais , Análise de Sobrevida , Distinções e Prêmios , Inibidor p16 de Quinase Dependente de Ciclina , Genes bcl-2 , Genes DCC , Biologia Molecular , Prognóstico , Progressão da Doença , Receptores de Fatores de Crescimento , Receptores do Fator de Crescimento Derivado de Plaquetas , Estudos Retrospectivos , Proteína Supressora de Tumor p53Assuntos
Humanos , Masculino , Adulto , Feminino , Pessoa de Meia-Idade , Neoplasias Encefálicas , Moléculas de Adesão Celular Neuronais/sangue , Biomarcadores Tumorais/sangue , Neoplasias Encefálicas , Estudos de Casos e Controles , Ependimoma , Glioma , Neoplasias Pulmonares , Melanoma , Meningioma , Moléculas de Adesão Celular Neuronais , Biomarcadores Tumorais , Neoplasias Hipofisárias , Isoformas de Proteínas , Neoplasias do Colo do ÚteroRESUMO
A protocol for shoot induction from callus of Haplophyllum patavinum was established. Two known furoquinoline (skimmianine and haplopine), and three quinolone (edulinine, ribalinine and isoplatydesmine) alkaloids were isolated for the first time from plant material, callus and shoot cultures of this species. The structures of these compounds have been characterised on the basis of spectroscopic evidence.
Assuntos
Alcaloides/isolamento & purificação , Compostos Heterocíclicos com 3 Anéis/isolamento & purificação , Plantas Medicinais/química , Quinolinas/isolamento & purificação , Quinolonas/isolamento & purificação , Rutaceae/química , Alcaloides/química , Técnicas de Cultura , Compostos Heterocíclicos com 3 Anéis/química , Itália , Espectrometria de Massas , Estrutura Molecular , Quinolinas/química , Quinolonas/química , Espectrometria de Massas por Ionização por ElectrosprayRESUMO
LP07 is a new cell line derived from P07 lung tumor, spontaneously arisen in a BALB/c mouse. LP07 is composed of heterogeneous epithelioid polyhedric cells that proliferate at a slow rate, have low plating efficiency and are unable to grow in soft agar. Only some LP07 cells expressed cytokeratins while most of them were positive for vimentin. Ultrastructure studies showed that LP07 cells established rudimentary intercellular unions, formed glandular-like conducts and presented conspicuous secretory granules, suggesting an epithelial-glandular origin, with neuroendocrine components. Upon injection LP07 cells formed poorly differentiated non-invasive adenocarcinomas, and tumor bearing mice developed leukocytosis, hypercalcemia and cachexia. This tumor cell line constitutes a useful tool to study lung tumor biology and paraneoplastic syndromes.
Assuntos
Adenocarcinoma/patologia , Divisão Celular/fisiologia , Neoplasias Pulmonares/patologia , Síndromes Paraneoplásicas/patologia , Adenocarcinoma/sangue , Animais , Contagem de Células Sanguíneas , Peso Corporal , Cálcio/sangue , Testes de Carcinogenicidade , Adesão Celular , Linhagem da Célula , Movimento Celular , Cromossomos/genética , Análise Citogenética , Modelos Animais de Doenças , Feminino , Técnicas Imunoenzimáticas , Neoplasias Pulmonares/sangue , Neoplasias Pulmonares/secundário , Camundongos , Camundongos Endogâmicos BALB C , Microscopia Eletrônica , Transplante de Neoplasias , Síndromes Paraneoplásicas/sangue , Células Tumorais Cultivadas , Ativador de Plasminogênio Tipo Uroquinase/metabolismoRESUMO
Target organ of metastasis determines the fate of metastasis. The soluble factors released from one or more cell types in the new stroma may influence growth and survival of metastatic cells. In the present study, we used conditioned media from the kidney, liver and lung, the latter being the target organ of metastasis of murine mammary adenocarcinoma cell lines LM3, LMM3 and F3II, to assess whether the soluble factors released from these organs could modulate in vitro survival of these cell lines after apoptosis-inducing treatments and to investigate the mechanisms involved in this effect. We demonstrate that conditioned medium from lung, but not from liver or kidney, promotes survival of these cells after doxorubicin, cisplatin, agonistic anti-Fas antibody and serum withdrawal treatments. Furthermore, LMM3 cells treated with lung conditioned medium after doxorubicin exposure maintained their tumorigenic capacity and metastatic potential. Neither IGF nor EGF could promote survival but, surprisingly, TGF-beta could reduce sensitivity of LMM3 cells to doxorubicin in vitro. Doxorubicin treatment induced Bax expression and down-regulated Bcl-2 expression. In contrast, lung conditioned medium increased Bcl-2 expression and inhibited doxorubicin-mediated Bcl-2 down-regulation. Neither of those treatments alone modified Bcl-X(L) expression, although co-treatment induced a 3- to 5-fold increase of its expression. These results suggest that the lung microenvironment could promote metastasis of these adenocarcinoma cell lines by increasing survival of metastatic cells, possibly by modulation of Bcl-2 protein family expression.
Assuntos
Adenocarcinoma/patologia , Apoptose , Regulação Neoplásica da Expressão Gênica , Rim/patologia , Fígado/patologia , Pulmão/patologia , Neoplasias Mamárias Animais/patologia , Metástase Neoplásica/patologia , Proteínas Proto-Oncogênicas c-bcl-2/biossíntese , Animais , Antineoplásicos/farmacologia , Sobrevivência Celular , Meios de Cultura , Doxorrubicina/farmacologia , Feminino , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Solubilidade , Células Estromais , Células Tumorais CultivadasRESUMO
There is accumulating evidence that cysteine proteinase activity plays an important role in cancer cell invasion and metastasis. Previously we demonstrated that cathepsin B (CB) plasma activity is increased in patients with transitional bladder cancer (TCC). In this work we have attempted to determine whether urine CB protein levels could be used as tumor marker in bladder cancer patients. Urine CB levels were evaluated employing a dot blot method, in 30 patients with TCC, 21 patients successfully treated from TCC without evidence of disease at the moment of urine collection (NED) and in 30 healthy volunteers. The median value (Md) of the control group was 3.8 microg CB/ml. Significantly higher urine CB values (Md: 5.9 microg/ml) were found in the TCC group. A high CB value was also found in the NED group (5.0 microg/ml). Urine CB values over the 5.2 microg/ml (cut-off point) were observed in 63% of TCC patients, 48% of NED and 8% of the control group. Only 4% NED patients had CB values over 13.0 microg/ml while 33% of TCC patients surpassed this value. Thus, urine CB might be a potential marker for transitional bladder cancer diagnosis.
Assuntos
Biomarcadores Tumorais/urina , Carcinoma de Células de Transição/urina , Catepsina B/urina , Neoplasias da Bexiga Urinária/urina , Adulto , Idoso , Idoso de 80 Anos ou mais , Carcinoma de Células de Transição/patologia , Carcinoma de Células de Transição/terapia , Intervalo Livre de Doença , Feminino , Humanos , Immunoblotting , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Sensibilidade e Especificidade , Neoplasias da Bexiga Urinária/patologia , Neoplasias da Bexiga Urinária/terapiaRESUMO
Matrix metalloproteinases (MMP) have been implicated in tumor invasion and metastasis. We verified, by gelatin zymography, MMP activity in the euglobulin plasma fraction of 82 healthy controls, 66 patients with benign diseases and 149 patients with breast, lung, colon or brain cancer. The euglobulin fractions assayed showed 4 gelatinolytic bands of 62, 92, 120 and 200 kDa. The median (Md) value for 92 kDa-MMP activity was significantly increased in breast (Md 1.34 arbitrary units [AU]/ml plasma, range 0.0-7.2) and lung cancer patients (Md 1.43 AU/ml, range 0.0-3.6) compared with the controls (Md 0.48 AU/ml, range 0.0-1.8). Patients with colon cancer or gliomas presented values of MMP-9 similar to those of the healthy population. Multivariate analysis indicated that plasma MMP-9 activity was not predicted by the known clinicopathological parameters such as age, stage, tumor size, number of positive lymph nodes, histologic grade, histologic type, nuclear grade or mitotic index. Lung cancer patients also presented high values of MMP-9 (Md 1.43, range 0.0-3.6 [n = 26]), without association with tumor stage or histologic type. The levels of 92 kDa-MMP activity in the plasma euglobulin fraction could be a potentially useful tumor marker in breast and lung cancer.
Assuntos
Biomarcadores Tumorais/sangue , Neoplasias da Mama/enzimologia , Neoplasias Pulmonares/enzimologia , Metaloproteinase 2 da Matriz/sangue , Metaloproteinase 9 da Matriz/sangue , Soroglobulinas/metabolismo , Adenocarcinoma/sangue , Adenocarcinoma/enzimologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Astrocitoma/sangue , Astrocitoma/enzimologia , Neoplasias Encefálicas/sangue , Neoplasias Encefálicas/enzimologia , Neoplasias da Mama/sangue , Neoplasias do Colo/sangue , Neoplasias do Colo/enzimologia , Feminino , Glioblastoma/sangue , Glioblastoma/enzimologia , Humanos , Neoplasias Pulmonares/sangue , Masculino , Pessoa de Meia-IdadeRESUMO
Tumor invasion and metastasis development is a multistep process involving adhesion molecules as well as tumor proteases. It has been reported that tumor cells lacking fibronectin (FN) expression and engineered to re-express FN showed a marked reduction in metastatic ability. Besides its effects on cell adhesion and migration, FN could be modulating other cellular events associated with the metastatic cascade. To test this hypothesis, we analyzed the production of urokinase-type plasminogen activator (uPA), and its receptor (uPAR), 2 molecules involved in the invasive phenotype, in cells over-expressing RGD wild-type FN (FNwt clones) or RGD-mutated FN (FN RGD-minus clones). Secreted uPA activity and antigen were significantly up-regulated in FN-expressing clones, although RGD-minus cells secreted approximately 50% less uPA than the FNwt ones. Interestingly, while control and FN RGD-minus clones were able to readily bind uPA to their surface, FNwt clones exhibited impaired uPA binding. Furthermore, treatment of the parental cell line as well as the control and FN-expressing clones with exogenous purified FN or RGD peptides induced up-regulation of uPA production and the reduction of uPA membrane binding, which was associated with lower expression of uPAR. This modulation by FN was found to be dependent on RGD sequence and beta1 integrin. These results strongly suggest a novel activity for the multifunctional glycoprotein FN regarding the regulation of uPA production as well as the capacity of tumor cells to bind uPA.
Assuntos
Antineoplásicos/metabolismo , Fibronectinas/metabolismo , Neoplasias Mamárias Animais/enzimologia , Ativador de Plasminogênio Tipo Uroquinase/biossíntese , Animais , Movimento Celular , Indução Enzimática , Fibronectinas/genética , Integrina beta1/fisiologia , Neoplasias Mamárias Animais/patologia , Camundongos , Oligopeptídeos/fisiologia , Ligação Proteica , Receptores de Superfície Celular/biossíntese , Receptores de Superfície Celular/fisiologia , Receptores de Ativador de Plasminogênio Tipo Uroquinase , Células Tumorais Cultivadas , Ativador de Plasminogênio Tipo Uroquinase/metabolismoRESUMO
The ability of tumor cells to respond to microenvironmental factors present in the target organ determines in part the successful development of a metastasis. In a previous work it was demonstrated that the conditioned medium (CM) from lungs of normal mice stimulates in vitro migration, proliferation and uPA activity of cells from a murine mammary adenocarcinoma moderately metastatic to lung. This CM also enhanced local and metastatic tumor growth. Here, we show that lung CM enhanced neovascularization when inoculated together with LM3 tumor cells into the skin of syngeneic mice. A similar tumor-induced angiogenesis response was obtained when lung CM was injected systemically. Western blot analysis of lung CM revealed the presence of some laminin fragments containing the sequence SIKVAV. To determine whether those molecules were responsible for the observed angiogenic effects, the CM was depleted of the peptides containing the SIKVAV sequence. We observed that the SIKVAV-depleted lung CM lost its ability to induce an enhancement of the tumor neovascular response. Our results suggest a role for the target organ in facilitating the neovascularization of tumor cells, probably through the participation of active peptides derived from the proteolytic degradation of the basement membrane component laminin.